Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07529639) titled 'Tumor Budding and T1 Substaging in Urothelial Bladder Cancer' on April 8.

Study Type: Observational

Primary Sponsor: Assiut University

Condition: Urothelial Bladder Carcinoma Bladder Carcinoma Non-Muscle-Invasive Bladder Cancer (NMIBC) Muscle-Invasive Bladder Cancer (MIBC)

Recruitment Status: Not recruiting

Date of First Enrollment: May 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07529639

Disclaimer: Curated by HT Syndication....